A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(4 sites)

United States

Duplicate_Henry Ford Health System /ID# 209090, Detroit, Michigan

Dartmouth-Hitchcock Medical Center /ID# 169097, Lebanon, New Hampshire

Gabrail Cancer Center Research /ID# 207039, Canton, Ohio

Australia

Peter MacCallum Cancer Centre-East Melbourne /ID# 225247, East Melbourne, Victoria